Document:

<PAGE>
                                                                   Exhibit 10.22

                                                                  EXECUTION COPY

     NEITHER THIS NOTE NOR THE SECURITIES ISSUABLE PURSUANT HERETO HAVE BEEN
     REGISTERED OR QUALIFIED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
     APPLICABLE FOREIGN OR STATE SECURITIES LAWS. THIS NOTE AND SUCH SECURITIES
     MAY NOT BE TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS THEY HAVE BEEN SO
     REGISTERED AND QUALIFIED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE
     COMPANY TO THE EFFECT THAT SUCH REGISTRATION AND QUALIFICATION IS NOT
     REQUIRED HAS BEEN DELIVERED TO THE COMPANY.

                             8% SENIOR NOTE DUE 2006

No. 3                                                              March 3, 2005
$761,800.00

     FOR VALUE RECEIVED, EpiCept Corporation, a Delaware corporation (the
"COMPANY"), hereby promises to pay to the order of SANDERS OPPORTUNITY FUND
(INSTITUTIONAL), L.P. and its successors and assigns (the "Holder"), the
principal sum of SEVEN HUNDRED SIXTY ONE THOUSAND EIGHT HUNDRED DOLLARS
($761,800.00) (the "PRINCIPAL AMOUNT"), on the terms and conditions set forth in
the Note Purchase Agreement, dated as of March 3, 2005 (the "PURCHASE
AGREEMENT"), among the Company and the Purchasers identified on Annex A and
Annex B thereto (the "PURCHASERS"). Subject to the conversion, prepayment and
default provisions set forth in this Note and the Purchase Agreement, all
outstanding principal and accrued and unpaid interest under this Note shall
become due and payable on October 30, 2006.

     Payments of principal of, interest on and any premium with respect to this
Note are to be made in lawful money of the United States of America by check
mailed and addressed to the registered Holder hereof at the address shown in the
register maintained by the Company for such purpose, or, at the option of the
Holder, in such manner and at such other place in the United States of America
as the Holder hereof shall have designated to the Company in writing.

     Notwithstanding any provision to the contrary in this Note, the Purchase
Agreement or any other agreement, the Company shall not be required to pay, and
the Holder shall not be permitted to contract for, take, reserve, charge or
receive, any compensation which constitutes interest under applicable law in
excess of the maximum amount of interest permitted by law.

     This Note is one of a series of 8% Senior Notes Due 2006 (herein called the
"NOTES") issued pursuant to the Purchase Agreement and is entitled to the
benefits thereof. All capitalized terms used herein but not otherwise defined
shall have the meanings ascribed to them in the Purchase Agreement. Each Holder
of this Note will be deemed, by its acceptance hereof, to have agreed to the
provisions and to have made the representations and warranties set forth in
Article 6 of the Purchase Agreement.
<PAGE>
     This Note is transferable only by surrender hereof in accordance with
Article 7 of the Purchase Agreement, duly endorsed or accompanied by a written
instrument of transfer duly executed by the registered Holder of this Note.

     This Note is also subject to optional prepayment, in whole or in part, at
the times and on the terms specified in the Purchase Agreement.

     This Note is also subject to mandatory prepayment on the terms specified in
the Purchase Agreement.

     If the Company fails to consummate an initial public offering (the "INITIAL
PUBLIC OFFERING") and thereafter consummates a debt or equity financing with
gross proceeds to the Company of at least $15,000,000 (a "QUALIFYING
FINANCING"), then, simultaneously with the closing of such Qualifying Financing,
the outstanding principal and accrued and unpaid interest on this Note shall, at
the Holder's option, be converted into the number of securities determined by
dividing the principal amount, plus accrued and unpaid interest, outstanding at
the conversion date by the purchase or issue price of the securities sold or
issued in the Qualifying Financing. Such conversion shall occur at the lowest
price paid by any purchaser in the Qualifying Financing. To effect such
conversion, the Payee shall on or before the closing of the Qualifying Financing
become a party to all agreements between the Company and the purchasers in the
Qualifying Financing which set forth the terms and conditions of such purchase
and the Payee shall be entitled to all the rights granted to the purchasers
thereunder and subject to any restrictions or obligations imposed generally on
such purchasers. The Company will mail or cause to be mailed to the Payee a
notice specifying the date on which such Qualifying Financing is scheduled to
close. Such notice will be mailed at least twenty (20) days prior to the date of
such closing.

     If an Event of Default as defined in the Purchase Agreement occurs and is
continuing, the unpaid principal and accrued and unpaid interest on this Note
may be declared or otherwise become due and payable in the manner, at the price
(including any applicable premium) and with the effect provided in the Purchase
Agreement.

     Time is of the essence of this Note. To the fullest extent permitted by
applicable law, the Company, for itself and its legal representatives,
successors and assigns, expressly waives presentment, demand, protest, notice of
dishonor, notice of maturity, notice of non-payment, notice of protest,
presentment for the purpose of accelerating maturity, diligence in collection,
and any exemption, each in respect of this Note.

     In no event, whether by reason of acceleration of the maturity of the
amounts due under the Note or otherwise, shall interest and fees contracted for,
charged, received, paid or agreed to be paid to the Holder exceed the maximum
amount permissible under applicable Law. If, from any circumstance whatsoever,
interest and fees would otherwise be payable to the Holder in excess of the
maximum amount permissible under applicable Law, the interest and fees shall be
reduced to the maximum amount permitted under such Law. If from any
circumstance, the Holder shall have received anything of value deemed interest
by applicable Law in excess of the maximum lawful amount, an amount equal to any
excess of interest shall be applied to the reduction of the principal amount of
the Notes, in such manner as may be determined by the

                                        2
<PAGE>
Holder, and not to the payment of fees or interest, or if such excess interest
exceeds the unpaid balance of the principal amount of the Notes, such excess
shall be refunded to the Company.

     Whenever possible, each provision of this Note shall be interpreted in such
manner as to be effective and valid under applicable Law, but if any provision
of this Note is held to be prohibited by or invalid under applicable Law in any
jurisdiction, such provision shall be ineffective only to the extent of such
prohibition or invalidity, without invalidating any other provision of this
Note.

     This Note and the rights and obligations of the parties hereto shall be
deemed to be contracts under the laws of the State of Delaware and for all
purposes shall be governed by and construed and enforced in accordance with the
laws of said State, except for its rules relating to the conflict of laws.

                                      * * *

                                        3
<PAGE>
     IN WITNESS WHEREOF, the Company has caused this Note to be executed and
delivered by its respective duly authorized officer as of the day and year and
at the place set forth above.

                                        EPICEPT CORPORATION

                                        By:   /s/ Robert W. Cook
                                              ---------------------------------
                                        Name:     Robert W. Cook
                                        Title:    Chief Financial Officer

                             SIGNATURE PAGE TO NOTE<PAGE>
                                                                   Exhibit 10.24

                                                                  EXECUTION COPY

     NEITHER THIS WARRANT NOR ANY SECURITIES THAT MAY BE ISSUED UPON EXERCISE
     HEREOF HAVE BEEN REGISTERED OR QUALIFIED UNDER THE SECURITIES ACT OF 1933,
     AS AMENDED, OR APPLICABLE FOREIGN OR STATE SECURITIES LAWS. THIS WARRANT
     AND SUCH SECURITIES MAY NOT BE TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS
     THEY HAVE BEEN SO REGISTERED AND QUALIFIED OR AN OPINION OF COUNSEL
     SATISFACTORY TO THE COMPANY TO THE EFFECT THAT SUCH REGISTRATION AND
     QUALIFICATION IS NOT REQUIRED HAS BEEN DELIVERED TO THE COMPANY.

                   AMENDED AND RESTATED STOCK PURCHASE WARRANT

                                                    Englewood Cliffs, New Jersey
                                                                 August 26, 2005

NO. B-7

     EpiCept Corporation, a Delaware corporation (the "Company"), hereby
certifies that, subject to the terms and conditions set forth herein, SANDERS
OPPORTUNITY FUND, L.P. (the "Holder"), is entitled to purchase the Warrant Share
Number of shares of Warrant Stock (both as defined below) from the Company at
any time or from time to time before the earliest of (i) 5:00 p.m. (New York
time) on March 3, 2008 (unless extended pursuant to Section 2(c) hereof), (ii)
the effective time of a Sale of the Company (as defined below) or (iii) at the
Effective Time (as defined in the Merger Agreement (as defined below) of the
Merger (as defined below), for the Exercise Price (as defined below), subject to
adjustments as set forth in Sections 5 and 7.

     This warrant was originally issued in connection with the purchase by the
Holder of a Senior Note of the Company in the principal amount set forth on the
signature page hereto. The Note is one of a series of notes issued to certain
investors in the aggregate maximum principal amount of $4,000,000 (collectively,
the "Senior Notes") and this warrant was originally issued as one of a series of
Stock Purchase Warrants (collectively, the "Warrants") issued in connection with
the issuance of the Senior Notes. This Amended and Restated Stock Purchase
Warrant (this "Warrant") is being issued pursuant to the terms of the Amended
and Restated Note Purchase Agreement, dated as of August 26, 2005, between the
Company and the Purchasers listed on the signature pages thereto (the "Note
Purchase Agreement").

1. Determination of Warrant Stock, Warrant Share Number and Warrant Exercise
Price.

     (a) Warrant Stock.

          (i) The term "Warrant Stock" shall mean shares of the Company's common
stock, $0.0001 par value per share (the "Common Stock").
<PAGE>
          (ii) If the Company consummates a Qualifying Financing (as defined in
the Note), then (A) the term "Warrant Stock" shall mean shares of Common Stock
or Preferred Stock ("Next Round Preferred Stock"), as the case may be, issued by
the Company in connection with the Qualifying Financing.

          (iii) If a Sale of the Company (as defined below) is anticipated to
occur prior to a Qualifying Financing or an IPO, the term "Warrant Stock" shall
mean shares of the Company's Common Stock, unless and until a Qualifying
Financing occurs or occurs prior to the Sale of the Company.

          (iv) Immediately prior to the Effective Time of the Merger (as defined
below) and thereafter, the term "Warrant Stock" shall mean shares of the
Company's Common Stock.

     (b) Warrant Share Number. This Warrant shall be exercisable for a number of
shares of Warrant Stock (the "Warrant Share Number") as follows:

          (i) If the Warrant Stock is Next Round Preferred Stock, the Warrant
Share Number shall equal 35% of the original principal amount of the Note (the
"Principal Amount") divided by the Exercise Price described in Section 1(c)(i)
below, such Warrant Share number to be rounded to the nearest whole number.

          (ii) If the Warrant Stock is Common Stock, the Warrant Share Number
shall equal 35% of the Principal Amount divided by the Public Offering Price (or
such other Exercise Price) described in Section 1(c)(ii) below, such Warrant
Share Number to be rounded to the nearest whole number.

     (c) Exercise Price. The exercise price per share of Warrant Stock (the
"Exercise Price") shall be as follows:

          (i) If the Warrant Stock is Next Round Preferred Stock, the Exercise
Price shall be the amount per share at which the Notes are converted into Next
Round Preferred Stock pursuant to the terms of the Note.

          (ii) If the Warrant Stock is Common Stock, the Exercise Price shall be
$0.99 (subject to adjustment as provided in Section 4 hereof); provided that if
a Qualifying Financing has occurred and Common Stock was issued in the
Qualifying Financing then the Exercise Price shall be the price per share at
which the Notes are converted into Common Stock pursuant to the terms of the
Note.

     (d) Defined Terms. For purposes of this Section 1, the following terms
shall have the following meanings:

          (i) "IPO" shall mean a Qualified Public Offering, as such term is
defined in the Certificate of Incorporation (as defined in Section 5 below).

          (ii) "Public Offering Price" shall mean the price at which the Common
Stock is sold to the public in an IPO.

                                        2
<PAGE>
2. Exercise of Warrant.

     (a) Mechanics of Exercise. This Warrant may be exercised by the registered
holder hereof by surrender to the Company of this Warrant, with the attached
form of subscription agreement duly executed by such holder, accompanied by
payment equal to the aggregate purchase price for the securities for which this
Warrant is then being exercised according to Section 4 hereof. Each Regulation S
Purchaser (as defined in the Note Purchase Agreement) wishing to exercise this
Warrant must also deliver (i) a written certification to the Company that such
holder is not a U.S. person (as defined in Regulation S under the Securities
Act) and this Warrant is not being exercised on behalf of a U.S. person or (ii)
a written opinion of counsel to the effect that this Warrant and the securities
to be delivered upon exercise hereof have been registered under the Securities
Act or are exempt from registration thereunder.

     (b) Warrant Agent. In the event that a bank or trust company is appointed
as trustee for the holder of this Warrant pursuant to Section 4(b) hereof, such
bank or trust company will have all the powers and duties of a warrant agent
appointed pursuant to Section 9 hereof and will accept, in its own name for the
account of the Company or such successor entity as may be entitled thereto, all
amounts otherwise payable to the Company or such successor, as the case may be,
upon exercise of this Warrant.

     (c) Expiration. This Warrant and the holder's rights hereunder will expire
on the earliest of (a) 5:00 P.M. (New Jersey time) on March 3, 2008 (the
"Expiration Date"); provided, however, that if an IPO has not been consummated
on or prior to the first anniversary of the date hereof, the Expiration Date
shall be extended to March 3, 2009, (b) the effective time of a Sale of the
Company or (c) the repayment of the Holder's Senior Notes. If the Warrant Stock
is Next Round Preferred Stock, then upon and after the Automatic Conversion
Effective Time (as defined in Section 6), the right to purchase shares of
Warrant Stock granted herein shall terminate, and this Warrant shall represent
the right to purchase shares of Common Stock, as provided in Section 6 hereof.
For purposes hereof, a "Sale of the Company" means (a) a merger, consolidation,
share exchange or other form of corporate reorganization involving the Company
in which the stockholders of the Company immediately before such merger,
consolidation, share exchange or other corporate reorganization dispose of in
excess of fifty percent (50%) of the issued and outstanding capital stock of the
Company; (b) any transaction or series of related transaction in which (i) all
or substantially all of the assets of the Company are sold, or (ii) excess of
fifty percent (50%) of the shares of Common Stock (assuming conversion of all
convertible securities) is issued transferred to any person (other than in a
Qualifying Financing); or (c) any event that would trigger payments to the
holders of any series of the Preferred Stock under Section 1(c) of Article
FOURTH of the Current Charter in the absence of the prescribed vote of the
holders of such series to the contrary and "Merger" means the merger of a wholly
owned subsidiary of the Company with and into Maxim Pharmaceuticals Inc.
("Maxim") pursuant to that certain Agreement and Plan of Merger (the "Merger
Agreement") among the Company, Magazine Acquisition Corp. and Maxim dated as of
September 6, 2005.

     (d) Delivery of Certificates. As soon as is practicable after any exercise
of this Warrant, the Company, at its own expense, will deliver to the registered
holder hereof one or more certificates representing the securities to which such
holder is entitled in respect of such

                                        3
<PAGE>
exercise, together, in the case of any partial exercise, with a new Warrant
representing the unexercised portion hereof.

     (e) Fractional Shares. In the event that any exercise of this Warrant
would, but for the provisions of this Section 2(e), result in the issuance of
any fractional share of capital stock, then in lieu of such fractional share,
such shares shall be rounded up to the nearest whole number of shares of capital
stock.

     (f) Deemed Exercise. Effective immediately prior to the Effective Time of
the Merger, without further act on the part of the Holder, this Warrant shall be
deemed to be exercised for the number of shares of Common Stock calculated
pursuant to Section 1(b)(ii) hereof. Payment of the Exercise Price shall be
deemed paid by the net issuance method described in Section 3(b)(ii) hereof. For
the avoidance of doubt, upon the closing of the Merger, assuming that there are
no stock splits, combinations or dividends (other than the reverse stock split
contemplated by the Merger Agreement), this Warrant shall be exchanged for
21,053 shares of Common Stock.

3. Payment of Exercise Price. The Exercise Price may be paid at the holder's
election either (a) by cash, certified or official bank check payable to the
order of the Company, or wire transfer to its account, or (b) by the net
issuance method as described below:

          (i) If the Warrant Stock is Next Round Preferred Stock, then prior to
the Automatic Conversion Effective Time (as defined in Section 7 hereof), the
Company shall issue Warrant Stock under the net issuance method in accordance
with the following formula:

       X = (Y)(A-B)/A

Where: X = the number of shares of Warrant Stock to be issued to the holder

       Y = the number of shares of Warrant Stock requested to be exercised under
           this Warrant

       A = the current fair market value of one (1) share of Warrant Stock

       B = the Exercise Price

     As used herein, the current fair market value of a share of Warrant Stock
shall mean the price per share which the Company could obtain from a willing
buyer (not a current employee or director) for shares of Warrant Stock, as
determined in good faith by the Company's Board of Directors, unless the Company
shall become subject to a merger, consolidation or other acquisition pursuant to
which the holders of Warrant Stock receive securities and/or other property in
exchange for their Warrant Stock, in which case the fair market value of Warrant
Stock shall be deemed to be the value (determined in good faith by the Company's
Board of Directors of the securities and other property received by the holders
of the Company's Warrant Stock per share of Warrant Stock pursuant to such
merger, consolidation or other acquisition.

          (ii) If the Warrant Stock is Common Stock, or if this Warrant is
exercised either upon or after the Automatic Conversion Effective Time, the
Company shall issue Common Stock under the net issuance method in accordance
with the following formula:

                                        4
<PAGE>
       X = (Y)(A-B)/A

Where: X = the number of shares of Common Stock to be issued to the holder

       Y = the number of shares of Common Stock requested to be exercised under
           this Warrant

       A = the current fair market value of one (1) share of Common Stock

       B = the Exercise Price

     As used herein, current fair market value of Common Stock shall mean with
respect to each share of Common Stock:

          (A) if the exercise is in connection with the Company's initial public
offering of Common Stock, and if the Company's registration statement relating
to such public offering has been declared effective by the Securities and
Exchange Commission, then the initial "Price to Public" specified in the final
prospectus with respect to the offering;

          (B) if this Warrant is exercised after, and not in connection with,
the Company's initial public offering of Common Stock or the Company's Common
Stock is otherwise registered under the Securities Exchange Act of 1934, as
amended, and

               (1) if the Common Stock is traded on a national securities
exchange or quoted on the Nasdaq Stock Market, the fair market value shall be
deemed to be the average of the closing prices over a ten (10) day period ending
three days before the day the current fair market value of the Common Stock is
being determined; or

               (2) if the Common Stock is not listed on a national securities
exchange or quoted on the Nasdaq Stock Market but is actively traded
over-the-counter, the fair market value shall be deemed to be the average of the
closing bid and asked prices reported by the National Quotation Bureau (or
similar system) over the ten (10) day period ending three days before the day
the current fair market value of the Common Stock is being determined;

          (C) if at any time the Common Stock is not listed on any national
securities exchange or quoted on the Nasdaq Stock Market or actively traded in
the over-the-counter market, the current fair market value of Common Stock shall
be the price per share which the Company could obtain from a willing buyer (not
a current employee or director) for shares of Common Stock sold by the Company,
from authorized but unissued shares, as determined in good faith by its Board of
Directors, unless the Company shall become subject to a merger, consolidation or
other acquisition pursuant to which the holders of Common Stock receive
securities and/or other property in exchange for their Common Stock, in which
case the fair market value of Common Stock shall be deemed to be the value of
the securities and other property received by the holders of the Company's
Common Stock per share of Common Stock pursuant to such merger, consolidation or
other acquisition.

          (D) In connection with a deemed exercise of this Warrant upon
consummation

                                        5
<PAGE>
of the Merger, the current fair market value of one (1) share of Common Stock
shall be $1.32.

4. Adjustment for Reorganizations, Etc.

     (a) Certain Adjustments.

          (i) If the Warrant Stock is Next Round Preferred Stock, then in case
at any time or from time to time prior to the exercise of this Warrant but
before the Automatic Conversion Effective Time, the Company effects an
"Extraordinary Warrant Stock Event" (as hereafter defined), then in each such
case, (A) the number of shares of Warrant Stock purchasable hereunder shall be
adjusted to the number obtained by multiplying the number of shares of Warrant
Stock purchasable hereunder immediately before such Extraordinary Warrant Stock
Event by a fraction, the numerator of which shall be the number of shares of
Warrant Stock outstanding (excluding treasury stock) immediately after such
Extraordinary Warrant Stock Event and the denominator of which shall be the
number of shares of Warrant Stock outstanding (excluding treasury stock)
immediately before such Extraordinary Warrant Stock Event, and (B) the Exercise
Price shall be adjusted to the number obtained by multiplying the Exercise Price
in effect immediately before such Extraordinary Warrant Stock Event by a
fraction, the numerator of which shall be the number of shares of Warrant Stock
outstanding (excluding treasury stock) immediately before such Extraordinary
Warrant Stock Event and the denominator of which shall be the number of shares
of Warrant Stock outstanding (excluding treasury stock) immediately after such
Extraordinary Warrant Stock Event, in each case subject to further adjustment
thereafter as provided herein. The term "Extraordinary Warrant Stock Event"
shall mean (x) the issuance of additional shares of Warrant Stock as a dividend
or other distribution on outstanding Warrant Stock, (y) the subdivision of
outstanding shares of Warrant Stock into a greater number of shares of Warrant
Stock, or (z) the combination of outstanding shares of Warrant Stock into a
smaller number of shares of Warrant Stock.

          (ii) If the Warrant Stock is Common Stock or if at any time or from
time to time prior to the exercise of this Warrant but after the Automatic
Conversion Effective Time, the Company effects an "Extraordinary Common Stock
Event" (as hereafter defined), then in each such case, (A) the number of shares
of Common Stock purchasable hereunder shall be adjusted to the number obtained
by multiplying the number of shares of Common Stock purchasable hereunder
immediately before such Extraordinary Common Stock Event by a fraction, the
numerator of which shall be the number of shares of Common Stock outstanding
(excluding treasury stock) immediately after such Extraordinary Common Stock
Event and the denominator of which shall be the number of shares of Common Stock
outstanding (excluding treasury stock) immediately before such Extraordinary
Common Stock Event, and (B) the Exercise Price shall be adjusted to the number
obtained by multiplying the Exercise Price in effect immediately before such
Extraordinary Common Stock Event by a fraction, the numerator of which shall be
the number of shares of Common Stock outstanding (excluding treasury stock)
immediately before such Extraordinary Common Stock Event and the denominator of
which shall be the number of shares of Common Stock outstanding (excluding
treasury stock) immediately after such Extraordinary Common Stock Event, in each
case subject to further adjustment thereafter as provided herein. The term
"Extraordinary Common Stock Event" shall mean (x) the issuance of additional
shares of Common Stock as a dividend or other distribution on outstanding Common
Stock, (y) the subdivision of outstanding shares of Common Stock into a greater
number of

                                        6
<PAGE>
shares of Common Stock, or (z) the combination of outstanding shares of Common
Stock into a smaller number of shares of Common Stock.

          (iii) Subject to earlier termination of this Warrant upon a Sale of
the Company or the Merger, at any time or from time to time prior to the
exercise of this Warrant, the Company (A) effects a capital reorganization,
reclassification or recapitalization, or (B) consolidates with or merges with or
into any other person or entity, then in each such case, the registered holder
of this Warrant, upon exercise hereof at any time after or simultaneously with
the consummation of such reorganization, reclassification, recapitalization,
consolidation or merger, as the case may be, will receive, in lieu of the
securities issuable upon such exercise before such consummation or effective
date, the other securities, cash, and/or property to which such holder would
have been entitled upon such consummation or in connection with such
dissolution, as the case may be, if such holder had exercised this Warrant
immediately prior thereto, all subject to further adjustment thereafter as
provided herein.

     (b) Appointment of Trustee for Warrant Holders Upon Dissolution. In the
event of any dissolution of the Company, the Company, prior to such dissolution,
will, at its expense, deliver or cause to be delivered the securities, property,
and/or cash receivable by the registered holder of this Warrant after the
effective date of such dissolution pursuant to this Section 5 to a bank or trust
company having its principal office in Delaware, as trustee for the registered
holder of this Warrant.

     (c) Continuation of Terms. Subject to earlier termination of this Warrant
upon a Sale of the Company or the Merger, upon any reorganization, consolidation
or merger referred to in this Section 5, this Warrant will continue in full
force and effect and the terms hereof will be applicable to the securities,
cash, and/or property receivable on the exercise of this Warrant after or
simultaneously with the consummation of such reorganization, consolidation or
merger and will be binding upon the issuer of any such stock or other
securities.

5. No Dilution or Impairment. The Company will not, by amendment of its
Certificate of Incorporation (as amended and/or restated from time to time, the
"Certificate of Incorporation") or through any reorganization, transfer of
assets, consolidation, merger, dissolution, issue or sale of securities, or any
other action, avoid or seek to avoid the observance or performance of any of the
terms of this Warrant, but will at all times in good faith assist in the
carrying out of all such terms and in the taking of all such action as may be
necessary or appropriate in order to protect the rights of the registered holder
of this Warrant against dilution. Without limiting the generality of the
foregoing, the Company will take all such action as may be necessary or
appropriate in order that the Company may validly and legally issue fully paid
and nonassessable shares of stock upon exercise of this Warrant from time to
time.

6. Automatic Conversion of the Warrant Stock. If the Warrant Stock is Next Round
Preferred Stock and at any time the issued and outstanding shares of the Warrant
Stock shall be automatically converted into shares of Common Stock under the
terms of the Certificate of Incorporation, then upon and after the effective
time of such automatic conversion of the Warrant Stock (the "Automatic
Conversion Effective Time"), the right to purchase Warrant Stock granted herein
shall terminate, and this Warrant shall represent the right to purchase a number
of shares of Common Stock calculated as follows:

                                        7
<PAGE>
       X = (Y) (Z)

Where: X = the number of shares of Common Stock purchasable under this Warrant
           upon and after such Automatic Conversion Effective Time

       Y = the number of shares of Warrant Stock purchasable under this
           Warrant immediately prior to such Automatic Conversion Effective Time

       Z = the number of shares of Common Stock issuable upon conversion of each
           share of Warrant Stock immediately prior to such Automatic Conversion
           Effective Time

and the Exercise Price per share of Common Stock shall be a price calculated as
follows:

       A = (B)(X)/Y

Where: A = the Exercise Price per share of Common Stock upon and after such
           Automatic Conversion Effective Time

       B = the Exercise Price per share of Warrant Stock immediately prior to
           such Automatic Conversion Effective Time

       X = the number of shares of Warrant Stock purchasable under this Warrant
           immediately prior to such Automatic Conversion Effective Time

       Y = the number of shares of Common Stock purchasable under this Warrant
           upon and after such Automatic Conversion Effective Time

Thereafter, the number of shares of Common Stock purchasable hereunder and the
Exercise Price per share shall be subject to adjustment for the types of events
described in Section 5 above that occur with respect to the Common Stock.

7. Notices of Record Date, Etc. In the event from time to time of any proposed
or contemplated:

     (a) taking by the Company of a record of the holders of any class of
securities for the purpose of determining the holders thereof who are entitled
to receive any dividend or other distribution, or any right to subscribe for,
purchase, or otherwise acquire any shares of stock of any class or any other
securities or property, or to receive any other right;

     (b) capital reorganization of the Company, any reclassification or
recapitalization of the capital stock of the Company, or any transfer of all or
substantially all the assets of the

                                        8
<PAGE>
Company to, or any consolidation or merger of the Company with or into, any
other person or entity; or

     (c) voluntary or involuntary dissolution, liquidation, or winding-up of the
Company;

then, and in each such event the Company will mail or cause to be mailed to the
registered holder of this Warrant a notice specifying (i) the date on which any
such record is to be taken for the purpose of such dividend, distribution, or
right, and stating the amount and character of such dividend, distribution, or
right, or (ii) the date on which any such reorganization, reclassification,
recapitalization, transfer, consolidation, merger, dissolution, liquidation, or
winding-up is anticipated to take place and the time, if any is to be fixed, as
of which the holders of record of any class or series of the Company's capital
stock or other securities will be entitled to exchange such stock or other
securities for other securities, cash, and/or other property deliverable on such
reorganization, reclassification, recapitalization, transfer, consolidation,
merger, dissolution, liquidation, or winding-up. Such notice will be mailed at
least twenty (20) days prior to the earliest date specified in such notice on
which any such action or transaction is to be taken or consummated.

8. Reservation of Securities Issuable on Exercise of Warrant. The Company at all
times and from time to time will reserve and keep available, solely for issuance
and delivery on the exercise of this Warrant, the quality and quantities of
securities from time to time issuable upon exercise of this Warrant. If at any
time the Company does not have sufficient authorized securities to comply with
the foregoing sentence, the Company promptly will take all steps (including,
without limitation, amending the Certificate of Incorporation) necessary to
provide the quality and quantity of securities sufficient to effect the exercise
in full of this Warrant.

9. Warrant Agent. The Company may, by written notice to the registered holder of
this Warrant, appoint an agent having an office in Delaware for the purpose of
issuing securities upon exercise of this Warrant, exchanging or replacing this
Warrant, or any of the foregoing, and thereafter any such issuance, exchange, or
replacement as the case may be, will be made at such office by such agent.

10. Transfer and Exchange of Warrant.

     (a) Transfer. This Warrant and any securities issuable upon exercise of
this Warrant may not be transferred or otherwise disposed of unless they have
been registered or qualified pursuant to the Securities Act of 1933, as amended
(the "Securities Act"), and applicable foreign or state securities laws, or an
opinion to the effect that such registration and qualification is not required
and has been delivered to the Company.

     (b) Exchange. Upon surrender of this Warrant for transfer or exchange, a
new Warrant or new Warrants of the same tenor and exercisable for the same
aggregate number of shares of Warrant Stock as the Warrant so surrendered will
be issued to, and registered in the name of, the transferee or transferees. The
Company may treat the person in whose name this Warrant is registered as the
holder hereof for all purposes.

                                        9
<PAGE>
11. Captions. The captions of sections or subsections of this Warrant are for
reference only and will not affect the interpretation or construction of this
Warrant.

12. Equitable Relief. The Company hereby acknowledges that any breach by it of
its obligations under this Warrant would cause substantial and irreparable
damage to the registered holder hereof and that money damages would be an
inadequate remedy therefor, and accordingly, acknowledges and agrees that, in
addition to any other rights and remedies to which the registered holder hereof
may be entitled in respect of any breach of such obligations, such holder will
be entitled to an injunction, specific performance and/or other equitable relief
to prevent the breach of such obligations.

13. Waivers. No waiver of any breach or default hereunder will be valid unless
in a writing signed by the registered holder hereof. No failure or other delay
by the registered holder hereof exercising any right, power, or privilege
hereunder will be or operate as a waiver thereof, nor will any single or partial
exercise thereof preclude any other or further exercise thereof or the exercise
of any other right, power, or privilege.

14. Governing Law. This Warrant will be governed by and interpreted and
construed in accordance with the internal laws of the State of Delaware (without
reference to principles of conflicts or choice of law).

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                       10
<PAGE>
     Executed and delivered under seal on and as of the date first above
written.

MAXIMUM NOTE PRINCIPAL: $238,200.00     EPICEPT CORPORATION

                                        By: /s/ Robert W. Cook
                                            ------------------------------------
                                            (signature)

                                        Name: Robert W. Cook
                                              (printed)

                                        Its: Chief Financial Officer
                                             (title)

ACCEPTED AND AGREED:

SANDERS OPPORTUNITY FUND, L.P.

BY: SOF MANAGEMENT, LLC

By: /s/ Don A. Sanders
    ---------------------------------
    (signature)

Name: /s/ Don A. Sanders
      -------------------------------
      (printed)

Its: Chief Investment Officer
     (title)
<PAGE>
                                SUBSCRIPTION FORM

     The undersigned, the registered holder of the within Stock Purchase
Warrant, hereby elects to exercise the purchase right represented by such
Warrant as follows:

___  The undersigned hereby elects to purchase ________ shares of Warrant Stock
     (as defined in this Warrant) and herewith makes payment of $_____________
     therefor.

___  The undersigned hereby elects to exercise this Warrant by the net issuance
     method described in Section 4 of this Warrant and to receive ___________
     shares of Warrant Stock (as defined in this Warrant).

     The undersigned further requests that the certificates representing such
shares be issued in the name of and delivered to
______________________________________ and if such shares shall not include all
of the shares issuable under this Warrant, that a new Warrant of like tenor and
date be delivered to the undersigned for the shares not issued.

Dated: _______________________          ___________________________________
                                        Name of Registered Holder

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00092-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00092-of-00352.parquet"}]]